Literature DB >> 16787844

Review of apoptosis vs. necrosis of substantia nigra pars compacta in Parkinson's disease.

R M Kostrzewa1.   

Abstract

The discovery that melanized neurons of the pars compacta of substantia nigra (pcSN) degenerate in the midbrain of human Parkinsonians is nearly a century old, but only in this decade have we gained insights into mechanisms underlying this neuronal loss. Although it had long been assumed that pcSN neurons underwent necrosis, recent (1) in vitro studies on isolated neurons, (2) in vivo studies in animals treated with neurotoxins, and (3) postmortem study of human Parkinsonian brain provide strong evidence that pcSN cells may be lost more from apoptosis (i.e., cell suicide) than from necrosis. This paper gives some historical perspective, but focuses primarily on mechanisms involved in both necrosis and apoptosis of neurons, primarily dopaminergic, and reviews the recent literature relating to apoptosis and apoptotic factors now identified in neurons undergoing neurotoxin-induced death and in postmortem human Parkinsonian brain. The weight of evidence in favor of apoptosis and apoptotic factors in these neurons, provides us with tools needed to develop anti-apoptotic factors that can be targeted to proteins on genes, so that it may be possible to decelerate or prevent the progressive neuronal cell loss in human Parkinsonians or in humans with other neurodegenerative disorders.

Entities:  

Year:  2000        PMID: 16787844     DOI: 10.1007/bf03033797

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  87 in total

1.  In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining.

Authors:  N A Tatton; S J Kish
Journal:  Neuroscience       Date:  1997-04       Impact factor: 3.590

2.  Direct evidence for glutathione as mediator of apoptosis in neuronal cells.

Authors:  A Nicole; D Santiard-Baron; I Ceballos-Picot
Journal:  Biomed Pharmacother       Date:  1998       Impact factor: 6.529

3.  Induction of apoptosis in catecholaminergic PC12 cells by L-DOPA. Implications for the treatment of Parkinson's disease.

Authors:  G Walkinshaw; C M Waters
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

4.  Glutathione transferases catalyse the detoxication of oxidized metabolites (o-quinones) of catecholamines and may serve as an antioxidant system preventing degenerative cellular processes.

Authors:  S Baez; J Segura-Aguilar; M Widersten; A S Johansson; B Mannervik
Journal:  Biochem J       Date:  1997-05-15       Impact factor: 3.857

5.  Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections.

Authors:  T G Hastings; D A Lewis; M J Zigmond
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

6.  The soluble form of Fas molecule is elevated in parkinsonian brain tissues.

Authors:  M Mogi; M Harada; T Kondo; Y Mizuno; H Narabayashi; P Riederer; T Nagatsu
Journal:  Neurosci Lett       Date:  1996-12-20       Impact factor: 3.046

7.  Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons.

Authors:  M M Tompkins; E J Basgall; E Zamrini; W D Hill
Journal:  Am J Pathol       Date:  1997-01       Impact factor: 4.307

8.  Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase.

Authors:  K Chiba; A Trevor; N Castagnoli
Journal:  Biochem Biophys Res Commun       Date:  1984-04-30       Impact factor: 3.575

9.  Secondary excitotoxicity contributes to dopamine-induced apoptosis of dopaminergic neuronal cultures.

Authors:  J Zhang; J O Price; D G Graham; T J Montine
Journal:  Biochem Biophys Res Commun       Date:  1998-07-30       Impact factor: 3.575

10.  Dopamine-induced programmed cell death in mouse thymocytes.

Authors:  D Offen; I Ziv; S Gorodin; A Barzilai; Z Malik; E Melamed
Journal:  Biochim Biophys Acta       Date:  1995-08-31
View more
  12 in total

1.  Neurotoxicological and neuroprotective elements in Parkinson's disease.

Authors:  Richard M. Kostrzewa; Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2002-03       Impact factor: 3.911

2.  Neuroprotective and neurorestorative strategies for neuronal injury.

Authors:  M F Beal; T Palomo; R M Kostrzewa; T Archer
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

3.  Effects of age, gender, and gonadectomy on neurochemistry and behavior in animal models of Parkinson's disease.

Authors:  Andrea Tamás; Andrea Lubics; István Lengvári; Dóra Reglodi
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

4.  Dopaminochrome induces caspase-independent apoptosis in the mesencephalic cell line, MN9D.

Authors:  Andrew J Linsenbardt; Julie M Breckenridge; Gerald H Wilken; Heather Macarthur
Journal:  J Neurochem       Date:  2012-05-09       Impact factor: 5.372

5.  Ganglioside biosynthesis in developing brains and apoptotic cancer cells: X. regulation of glyco-genes involved in GD3 and Sialyl-Lex/a syntheses.

Authors:  Subhash Basu; Rui Ma; Joseph R Moskal; Manju Basu
Journal:  Neurochem Res       Date:  2012-04-10       Impact factor: 3.996

6.  Dual role of nanoparticles as drug carrier and drug.

Authors:  Hirak Kumar Patra; Anjan Kr Dasgupta; Sounik Sarkar; Indranil Biswas; Arnab Chattopadhyay
Journal:  Cancer Nanotechnol       Date:  2011-01-01

Review 7.  Stem cell therapy for Parkinson's disease using non-human primate models.

Authors:  Zhen-Zhen Chen; Yu-Yu Niu
Journal:  Zool Res       Date:  2019-09-18

Review 8.  Novel mechanisms and approaches in the study of neurodegeneration and neuroprotection. a review.

Authors:  Richard M Kostrzewa; Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.978

Review 9.  Genetic findings in Parkinson's disease and translation into treatment: a leading role for mitochondria?

Authors:  V Bogaerts; J Theuns; C van Broeckhoven
Journal:  Genes Brain Behav       Date:  2007-08-03       Impact factor: 3.449

10.  Activation of GSK-3β and caspase-3 occurs in Nigral dopamine neurons during the development of apoptosis activated by a striatal injection of 6-hydroxydopamine.

Authors:  Daniel Hernandez-Baltazar; Maria E Mendoza-Garrido; Daniel Martinez-Fong
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.